Zobrazeno 1 - 10
of 20
pro vyhledávání: '"V S Malichenko"'
Publikováno v:
Современная ревматология, Vol 0, Iss 1, Pp 32-38 (2012)
Objective: to evaluate bone tissue remodeling and mineral metabolism in elderly women who have not been previously examined and have received no antiosteoporotic therapy. Patients and methods. A total of 3152 women aged 65—75 years were examined us
Externí odkaz:
https://doaj.org/article/60962b878c3d404296fb428baa2434c1
Publikováno v:
Фармакоэкономика, Vol 16, Iss 4, Pp 657-670 (2024)
In recent decades, technological progress has contributed to a consistent change in approaches to organizing the provision of medical care in various regions of the world. Electronic data-gathering systems make it possible to create extensive informa
Externí odkaz:
https://doaj.org/article/d38bcc63685c487e9a54b48ea2907bdf
Autor:
V. S. Malichenko
Publikováno v:
Московский журнал международного права, Vol 0, Iss 4, Pp 6-20 (2022)
INTRODUCTION. Over the past decades under the influence of demographic processes, economic shocks, morbidity increase and other systemic problems a whole spectrum of threats to health has gradually formed at the international level, characterized by
Externí odkaz:
https://doaj.org/article/7d5548eacde0461ab7f02a51e79b4ff2
Autor:
A. Kh. ABASHIDZE, V. S. MALICHENKO
Publikováno v:
Московский журнал международного права, Vol 106, Iss 2, Pp 107-117 (2017)
Ensuring universal access to medicines is an important topic of the international agenda and national healthcare police. Access to medicines is determined by systemic interaction of a number of factors, including investment policy issues, intellectua
Externí odkaz:
https://doaj.org/article/8fb7deada32b4b09a79512d2a81314dd
Autor:
A. H. Abashidze, V. S. Malichenko
Publikováno v:
Московский журнал международного права, Vol 0, Iss 1, Pp 129-141 (2013)
The European Union is a market leader in clinical research, and this status requires uniform legislation in this area. However, all attempts to unify legislation had the opposite effect, leading to a reduction of investment in R & D area. To remedy t
Externí odkaz:
https://doaj.org/article/1cc60f1c2fa449c6a0cc50205f9c1ea8
Autor:
A. Kh. Abashidze, V. S. Malichenko
Publikováno v:
Courier of Kutafin Moscow State Law University (MSAL)). :26-41
Autor:
N V Putilo, V S Malichenko
Publikováno v:
Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny. 29(2)
In the Russian Federation, for long time legal uncertainty existed regarding relationship between the standards of medical care and clinical guidelines in organizing medical care support. In the actual legislation, there were no official definitions
Autor:
S. A Chandirli, Marina A. Shurgaya, M. A Dymochka, N. S Govorushkina, Sergey N. Puzin, S. A Boitsov, V. S Malichenko, Yu. D Krivoruchko
Publikováno v:
Medical and Social Expert Evaluation and Rehabilitation. 21:50-54
In 2012 Russia ratified the UN Convention on the Rights of Persons with Disabilities, which provides for the creation of an accessible environment for disabled people, ensuring their rights to work, medical care, education and full participation in p
Publikováno v:
Advances in gerontology = Uspekhi gerontologii. 31(4)
Disabled people remain one of the most vulnerable categories of population. Access to safe, quality and effective medicines as a key element of social well-being among people with disabilities remains of the priorities at the international agenda and
Publikováno v:
Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny. 24(4)
The diabetes mellitus acquires a character of sheer spreading global epidemic. Nowadays, in the Russian Federation number of patients with diabetes mellitus reaches 10 million. The accessibility of pharmaceuticals is one of main elements of support o